Literature DB >> 10405379

Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasma.

L M Kirstein1, J W Mellors, C R Rinaldo, J B Margolick, J V Giorgi, J P Phair, E Dietz, P Gupta, C H Sherlock, R Hogg, J S Montaner, A Muñoz.   

Abstract

We conducted two studies to determine the potential influence of delays in blood processing, type of anticoagulant, and assay method on human immunodeficiency virus type 1 (HIV-1) RNA levels in plasma. The first was an experimental study in which heparin- and EDTA-anticoagulated blood samples were collected from 101 HIV-positive individuals and processed to plasma after delays of 2, 6, and 18 h. HIV-1 RNA levels in each sample were then measured by both branched-DNA (bDNA) and reverse transcriptase PCR (RT-PCR) assays. Compared to samples processed within 2 h, the loss (decay) of HIV-1 RNA in heparinized blood was significant (P < 0.05) but small after 6 h (bDNA assay, -0.12 log(10) copies/ml; RT-PCR, -0.05 log(10) copies/ml) and after 18 h (bDNA assay, -0.27 log(10) copies/ml; RT-PCR, -0.15 log(10) copies/ml). Decay in EDTA-anticoagulated blood was not significant after 6 h (bDNA assay, -0.002 log(10) copies/ml; RT-PCR, -0.02 log(10) copies/ml), but it was after 18 h (bDNA assay, -0.09 log(10) copies/ml; RT-PCR, -0.09 log(10) copies/ml). Only 4% of samples processed after 6 h lost more than 50% (>/=0.3 log(10) copies/ml) of the HIV-1 RNA, regardless of the anticoagulant or the assay that was used. The second study compared HIV-1 RNA levels in samples from the Multicenter AIDS Cohort Study (MACS; samples were collected in heparin-containing tubes in 1985, had a 6-h average processing delay, and were assayed by bDNA assay) and the British Columbia Drug Treatment Program (BCDTP) (collected in EDTA- or acid citrate dextrose-containing tubes in 1996 and 1997, had a 2-h maximum processing delay, and were assayed by RT-PCR). HIV-1 RNA levels in samples from the two cohorts were not significantly different after adjusting for CD4(+)-cell count and converting bDNA assay values to those corresponding to the RT-PCR results. In summary, the decay of HIV-1 RNA measured in heparinized blood after 6 h was small (-0.05 to -0.12 log(10) copies/ml), and the minor impact of this decay on HIV-1 RNA concentrations in archived plasma samples of the MACS was confirmed by the similarity of CD4(+)-cell counts and assay-adjusted HIV-1 RNA concentrations in the MACS and BCDTP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10405379      PMCID: PMC85245     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma.

Authors:  J R Dyer; C D Pilcher; R Shepard; J Schock; J J Eron; S A Fiscus
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

2.  A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes.

Authors:  B van Gemen; R van Beuningen; A Nabbe; D van Strijp; S Jurriaans; P Lens; T Kievits
Journal:  J Virol Methods       Date:  1994-09       Impact factor: 2.014

3.  Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection.

Authors:  J Mulder; N McKinney; C Christopherson; J Sninsky; L Greenfield; S Kwok
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

4.  Stability of infectious HIV in clinical samples and isolation from small volumes of whole blood.

Authors:  S O'Shea; T Rostron; J E Mullen; J E Banatvala
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

5.  The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy.

Authors:  W J Boyko; M T Schechter; E Jeffries; B Douglas; M Maynard; M O'Shaughnessy
Journal:  Can Med Assoc J       Date:  1985-07-01       Impact factor: 8.262

6.  Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay.

Authors:  C Pachl; J A Todd; D G Kern; P J Sheridan; S J Fong; M Stempien; B Hoo; D Besemer; T Yeghiazarian; B Irvine
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-04-15

7.  Inhibition of human immunodeficiency virus gene amplification by heparin.

Authors:  M Holodniy; S Kim; D Katzenstein; M Konrad; E Groves; T C Merigan
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

8.  Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA, and p24 antigen from samples collected in VACUTAINER CPT and standard VACUTAINER tubes.

Authors:  L Mole; D Margolis; R Carroll; J Todd; M Holodniy
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

9.  Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction.

Authors:  R W Coombs; D R Henrard; W F Mehaffey; J Gibson; E Eggert; T C Quinn; J Phillips
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

10.  Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group.

Authors:  J V Giorgi; H L Cheng; J B Margolick; K D Bauer; J Ferbas; M Waxdal; I Schmid; L E Hultin; A L Jackson; L Park
Journal:  Clin Immunol Immunopathol       Date:  1990-05
View more
  11 in total

1.  Investigation of effects of acid citrate dextrose and EDTA on ability to quantitatively culture human immunodeficiency virus.

Authors:  C Jennings; J W Bremer; D J Brambilla
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

2.  Anticoagulants interfere with PCR used to diagnose invasive aspergillosis.

Authors:  Marta E García; Jose L Blanco; Jesús Caballero; Domingo Gargallo-Viola
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

3.  TaqMan real-time reverse transcription-PCR and JDVp26 antigen capture enzyme-linked immunosorbent assay to quantify Jembrana disease virus load during the acute phase of in vivo infection.

Authors:  Meredith Stewart; Moira Desport; Nining Hartaningsih; Graham Wilcox
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  An optimized sensitive method for quantitation of DNA/RNA viruses in heparinized and cryopreserved plasma.

Authors:  Ming Ding; Arlene Bullotta; Lori Caruso; Phalguni Gupta; Charles R Rinaldo; Yue Chen
Journal:  J Virol Methods       Date:  2011-05-17       Impact factor: 2.014

5.  HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection.

Authors:  Xiaojiang Gao; Thomas R O'Brien; Tania M Welzel; Darlene Marti; Ying Qi; James J Goedert; John Phair; Ruth Pfeiffer; Mary Carrington
Journal:  AIDS       Date:  2010-07-31       Impact factor: 4.177

6.  Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men.

Authors:  Mara M Epstein; Elizabeth Crabb Breen; Larry Magpantay; Roger Detels; Lauren Lepone; Sudhir Penugonda; Jay H Bream; Lisa Paula Jacobson; Otoniel Martínez-Maza; Brenda M Birmann
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-27       Impact factor: 4.254

7.  RT-PCR detection of HIV in Republic of Macedonia.

Authors:  Golubinka Bosevska; Nikola Panovski; Eleni Dokić; Violeta Grunevska
Journal:  Bosn J Basic Med Sci       Date:  2008-11       Impact factor: 3.363

8.  Viral Load Monitoring in HIV Infection.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.663

Review 9.  Expanding access to HIV viral load testing: a systematic review of RNA stability in EDTA tubes and PPT beyond current time and temperature thresholds.

Authors:  Kimberly Bonner; Reed A Siemieniuk; Andrew Boozary; Teri Roberts; Emmanuel Fajardo; Jennifer Cohn
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

10.  Genome-wide Long Non-coding RNA Analysis Identified Circulating LncRNAs as Novel Non-invasive Diagnostic Biomarkers for Gynecological Disease.

Authors:  Wen-Tao Wang; Yu-Meng Sun; Wei Huang; Bo He; Ya-Nan Zhao; Yue-Qin Chen
Journal:  Sci Rep       Date:  2016-03-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.